LL-37
ImmuneResearch only — not approvedCathelicidin
A human cathelicidin fragment logged as a research immune peptide.
- Typical form
- Lyophilized vial
- Typical route
- Subcutaneous
- Display unit
- mcg
- Typical vial
- 5 mg
- Half-life (approx.)
- 4 h
- Default in-use window
- 28 days
Educational · commonly logged
Typical protocol
A snapshot of how this compound is logged — not a prescription. You set every number.
- Common range
- 50–100 mcg
- Starting log
- 100 mcg
- Cadence
- Daily
- Timing
- Daily SubQ during a short run
- Duration
- 4–6 weeks
Small mcg draws. Injection reactions should be journaled. Research only.
Reconstitution note
Small mcg draws — watch unit readability.
Storage
Fridge after mix.
Cautions
Research only. Injection reactions should be journaled.
Evidence posture
Preclinical / early literature.